CoChat

Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study

Open access
Chiarotti, F, Viglione, A, Giuliani, A, Branchi, I · 2017 · Translational Psychiatry
Cited by 68

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Selective serotonin reuptake inhibitors (SSRIs), the most commonly prescribed antidepressant drugs, have a variable and incomplete efficacy. In order to better understand SSRI action, we explored the hypothesis that SSRIs do not affect mood per se but amplify the influence of the living conditions on mood. To this aim, we exploited the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) data set, selected a subpopulation of 591 patients with an overlapping clinical history and analyzed treatment outcome according to dosage −20 or 40 mg per day of citalopram. We found that sociodemographic characteristics affected treatment response in the same direction in the two dose groups, but these effects reached statistical significance only in the 40 mg per day dose group. In the latter, higher improvement rate was associated with having a working employment status (P=0.0219), longer education (P=0.0053), high income (P=0.01) or a private insurance (P=0.0031), and the higher remission rate was associated with having a working employment status (P=0.0326) or longer education (P=0.0484). Moreover, the magnitude of the effect of the sociodemographic characteristics on mood, measured as the percent of patients showing a positive outcome when exposed to favorable living conditions, was much greater—up to 37-fold—in the 40 compared to the 20 mg per day dose group. Overall, our results indicate that citalopram amplifies the influence of the living conditions on mood in a dose-dependent manner. These findings provide a potential explanation for the variable efficacy of SSRIs and might lead to the development of personalized strategies aimed at enhancing their efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/tp.2017.35

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 16

  1. Branchi I, Santarelli S, Capoccia S, Poggini S, D'Andrea I, Cirulli F et al. Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice. PLoS ONE 2013; 8: e62226. · DOI · Paper page
  2. Alboni S, Poggini S, Garofalo S, Milior G, El Hajj H, Lecours C et al. Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment. Brain Behav Immun 2016; 58: 261–271. · DOI · Paper page
  3. Bornstein SR, Schuppenies A, Wong ML, Licinio J . Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006; 11: 892–902. · DOI · Paper page
  4. Mastronardi C, Paz-Filho GJ, Valdez E, Maestre-Mesa J, Licinio J, Wong ML . Long-term body weight outcomes of antidepressant-environment interactions. Mol Psychiatry 2011; 16: 265–272. · DOI
  5. Downing RW, Rickels K . Predictors of response to amitriptyline and placebo in three outpatient treatment settings. J Nervous Ment Dis 1973; 156: 109–129. · DOI
  6. Keitner GI, Ryan CE, Miller IW, Norman WH . Recovery and major depression: factors associated with twelve-month outcome. Am J Psychiatry 1992; 149: 93–99. · DOI
  7. Perlis RH, Alpert J, Nierenberg AA, Mischoulon D, Yeung A, Rosenbaum JF et al. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg per day. Acta Psychiatr Scand 2003; 108: 432–438. · DOI
  8. Rickels K, Jenkins BW, Zamostien B, Raab E, Kanther M . Pharmacotherapy in neurotic depression. Differential population responses. J Nervous Ment Dis 1967; 145: 475–485. · doi:10.1097/00005053-196712000-00005
  9. Ronalds C, Creed F, Stone K, Webb S, Tomenson B . Outcome of anxiety and depressive disorders in primary care. Br J Psychiatry 1997; 171: 427–433. · DOI · Paper page
  10. Spillmann M, Borus JS, Davidson KG, Worthington JJ 3rd, Tedlow JR, Fava M . Sociodemographic predictors of response to antidepressant treatment. Int J Psychiatr Med 1997; 27: 129–136. · DOI
  11. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin N Am 2003; 26: 457–494, x. · DOI · Paper page
  12. Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK et al. Income and attrition in the treatment of depression: a STAR*D report. Depress Anxiety 2009; 26: 622–633. · DOI · Paper page
  13. Schmidt CO, Kohlmann T . When to use the odds ratio or the relative risk? Int J Public Health 2008; 53: 165–167. · DOI · Paper page
  14. Jain FA, Hunter AM, Brooks JO 3rd, Leuchter AF . Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety 2013; 30: 624–630. · DOI · Paper page
  15. Hahn B, Flood AB . No insurance, public insurance, and private insurance: do these options contribute to differences in general health? J Health Care Poor Underserved 1995; 6: 41–59. · doi:10.1353/hpu.2010.0333
  16. Belsky J . The differential susceptibility hypothesis: sensitivity to the environment for better and for worse. JAMA Pediatr 2016; 170: 321–322. · DOI

Cited by

See all 68

Metadata

Authors
Chiarotti, F., Viglione, A., Giuliani, A., & Branchi, I.
Venue
Translational Psychiatry
Published
2017-03-21
Volume
7
Issue
3
Pages
e1066-e1066
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2603032646
Cited by
68
References
10
FWCI
3.11
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study. https://app.cochat.ai/papers/10.1038/tp.2017.35
The paper
Chiarotti, F., Viglione, A., Giuliani, A., & Branchi, I. (2017). Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study. Translational Psychiatry. https://doi.org/10.1038/tp.2017.35

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.